US Clinical Laboratory Testing Market Assessment
The US represents an attractive destination for healthcare services’ market segments, especially clinical lab testing, which has evolved as a major source of decisive factor for healthcare professionals and that too despite garnering a low proportion of total medical spending. It is estimated that the market for clinical lab testing in the US reached to the mark of US$ 61 Billion in 2011 backed by factors, such as aging population, active private sector participation and rising awareness level. With the emergence of new technologies, the market is likely to register further to an optimum CAGR in future.
Currently, the market is dominated by routine testing followed by esoteric/molecular pathology tests and anatomic pathology. The future, however, holds significant promise for drug of abuse and anatomic pathology testing. The future growth in the US anatomic pathology (AP) segment is driven by strong growth in personalized laboratory testing on tumor tissues and other key factors. The report, in this context, offers effective information and analysis on the market landscape for key tests type with special emphasis on their future performance.
The US market for clinical laboratory diagnostics is highly fragmented with large number of labs offering services in different states of the country. Some players, however, have leading edge in comparison to other companies. Quest diagnostics, LabCorp and Sonic Healthcare are the key independent laboratories that have augmented their reach in the market with proper focus on consolidation activities. Our report entitled “US Clinical Laboratory Testing Market Assessment” provides an in-depth insight into the operations, services, M&A activities, financial performance and strengths and weaknesses of the key players in order to gauge their attractiveness in terms of investment and future participation in the market.
The report is an outcome of an in-depth research and prudent analysis of the US clinical laboratory testing market that emphasizes the reliability of data provided and presentation. It covers all the key aspects of market and investigates trends that are likely to impact the industry in the long run. Segment-wise analysis focuses upon the relevant information and key developments. Overall, the report is likely to be proved beneficial for all those entities who want to enter the market or make decisions regarding investment.
Currently, the market is dominated by routine testing followed by esoteric/molecular pathology tests and anatomic pathology. The future, however, holds significant promise for drug of abuse and anatomic pathology testing. The future growth in the US anatomic pathology (AP) segment is driven by strong growth in personalized laboratory testing on tumor tissues and other key factors. The report, in this context, offers effective information and analysis on the market landscape for key tests type with special emphasis on their future performance.
The US market for clinical laboratory diagnostics is highly fragmented with large number of labs offering services in different states of the country. Some players, however, have leading edge in comparison to other companies. Quest diagnostics, LabCorp and Sonic Healthcare are the key independent laboratories that have augmented their reach in the market with proper focus on consolidation activities. Our report entitled “US Clinical Laboratory Testing Market Assessment” provides an in-depth insight into the operations, services, M&A activities, financial performance and strengths and weaknesses of the key players in order to gauge their attractiveness in terms of investment and future participation in the market.
The report is an outcome of an in-depth research and prudent analysis of the US clinical laboratory testing market that emphasizes the reliability of data provided and presentation. It covers all the key aspects of market and investigates trends that are likely to impact the industry in the long run. Segment-wise analysis focuses upon the relevant information and key developments. Overall, the report is likely to be proved beneficial for all those entities who want to enter the market or make decisions regarding investment.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. US CLINICAL LABORATORY TESTING INDUSTRY
3.1 Current and Future Market Analysis to 2015
3.2 Market Division by Type of Tests
3.3 Market Division by Type of Lab
4. CONSOLIDATION: PICKING UP PACE IN LABORATORY TESTING
5. REGULATORY FRAMEWORK
5.1 Role of CLIA
5.2 Payment Mechanism
5.3 Drug Testing
5.4 Health Insurance Portability and Accountability Act of 1996 (HIPAA)
5.5 Laboratory Developed Tests (LDTs)
6. COMPETITIVE LANDSCAPE
6.1 Quest Diagnostics
6.1.1 Business Overview
6.1.2 Key Products and Services
6.1.3 Financial Overview
6.1.4 M&A Activity
6.1.5 Strengths and Weaknesses
6.2 Laboratory Corporation of America (LabCorp)
6.2.1 Business Overview
6.2.2 Key Products and Services
6.2.3 Financial Overview
6.2.4 M&A Activity
6.2.5 Strengths and Weaknesses
6.3 Bio-Reference Laboratories
6.3.1 Business Overview
6.3.2 Key Products and Services
6.3.3 Financial Overview
6.3.4 M&A Activity
6.3.5 Strengths and Weaknesses
6.4 Sonic Healthcare USA
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 M&A Activity
6.4.4 Strengths and Weaknesses
6.5 ARUP Laboratories
6.5.1 Business Overview
6.5.2 Key Products and Services
6.5.3 Strengths and Weaknesses
2. RESEARCH METHODOLOGY
3. US CLINICAL LABORATORY TESTING INDUSTRY
3.1 Current and Future Market Analysis to 2015
3.2 Market Division by Type of Tests
3.3 Market Division by Type of Lab
4. CONSOLIDATION: PICKING UP PACE IN LABORATORY TESTING
5. REGULATORY FRAMEWORK
5.1 Role of CLIA
5.2 Payment Mechanism
5.3 Drug Testing
5.4 Health Insurance Portability and Accountability Act of 1996 (HIPAA)
5.5 Laboratory Developed Tests (LDTs)
6. COMPETITIVE LANDSCAPE
6.1 Quest Diagnostics
6.1.1 Business Overview
6.1.2 Key Products and Services
6.1.3 Financial Overview
6.1.4 M&A Activity
6.1.5 Strengths and Weaknesses
6.2 Laboratory Corporation of America (LabCorp)
6.2.1 Business Overview
6.2.2 Key Products and Services
6.2.3 Financial Overview
6.2.4 M&A Activity
6.2.5 Strengths and Weaknesses
6.3 Bio-Reference Laboratories
6.3.1 Business Overview
6.3.2 Key Products and Services
6.3.3 Financial Overview
6.3.4 M&A Activity
6.3.5 Strengths and Weaknesses
6.4 Sonic Healthcare USA
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 M&A Activity
6.4.4 Strengths and Weaknesses
6.5 ARUP Laboratories
6.5.1 Business Overview
6.5.2 Key Products and Services
6.5.3 Strengths and Weaknesses
LIST OF FIGURES
Figure 3-1: Clinical Laboratory Testing Market (Billion US$), 2011-2015
Figure 3-2: Clinical Laboratory Testing Market by Type of Test (%), 2011
Figure 3-3: Clinical Laboratory Testing Market by Type of Lab (%), 2011
Figure 4-1: Number of Closed M&A Deals in Lab Testing Market (2001-2011)
Figure 5-1: Medicare Spending on Clinical Lab Fee Schedule (%), 2010
Figure 6-1: Sonic Healthcare USA - Revenue (Million AUD), 2010 & 2011
Figure 3-1: Clinical Laboratory Testing Market (Billion US$), 2011-2015
Figure 3-2: Clinical Laboratory Testing Market by Type of Test (%), 2011
Figure 3-3: Clinical Laboratory Testing Market by Type of Lab (%), 2011
Figure 4-1: Number of Closed M&A Deals in Lab Testing Market (2001-2011)
Figure 5-1: Medicare Spending on Clinical Lab Fee Schedule (%), 2010
Figure 6-1: Sonic Healthcare USA - Revenue (Million AUD), 2010 & 2011
LIST OF TABLES
Table 6-1: Quest Diagnostics - Key Products and Services
Table 6-2: Quest Diagnostics - Financial Performance (Million US$), 2009-2011
Table 6-3: Quest Diagnostics - Key M&As Activities
Table 6-4: LabCorp - Key Products and Services
Table 6-5: LabCorp - Financial Performance (Million US$), 2009-2011
Table 6-6: LabCorp - Key M&As Activities
Table 6-7: Bio-Reference Labs - Key Products and Services
Table 6-8: Bio-Reference Labs - Financial Performance (Million US$), 2009-2011
Table 6-9: Sonic Healthcare USA - Key M&As Activities
Table 6-10: ARUP Laboratories - Key Products and Services
Table 6-1: Quest Diagnostics - Key Products and Services
Table 6-2: Quest Diagnostics - Financial Performance (Million US$), 2009-2011
Table 6-3: Quest Diagnostics - Key M&As Activities
Table 6-4: LabCorp - Key Products and Services
Table 6-5: LabCorp - Financial Performance (Million US$), 2009-2011
Table 6-6: LabCorp - Key M&As Activities
Table 6-7: Bio-Reference Labs - Key Products and Services
Table 6-8: Bio-Reference Labs - Financial Performance (Million US$), 2009-2011
Table 6-9: Sonic Healthcare USA - Key M&As Activities
Table 6-10: ARUP Laboratories - Key Products and Services
